A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia

计划入组 560 人 · 首次发布于 2025 年 10 月 31 日

Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.

计划入组 2 人 · 首次发布于 2008 年 8 月 27 日

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

计划入组 100 人 · 首次发布于 2023 年 2 月 28 日

AM E3-SG-3249

Acute myeloid leukaemia vaccine (AVAX Technologies)

4SCAR19U T cell therapy (B-cell acute lymphoblastic leukemia/B-cell lymphoma)

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

Josep Carreras Leukaemia Research Institute

Spain

AB&B BIO-TECH-B

Real-World Study Confirms Blinatumomab Effectiveness as Bridge to Transplant in B-Cell Precursor ALL

FDA Approves Autolus's AUCATZYL (obecabtagene autoleucel) CAR-T Therapy for Adult ALL

FDA Approves Obecabtagene Autoleucel (Obe-cel) for Relapsed/Refractory B-Cell ALL